午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Hubei Moxin Biotechnology Co., Ltd

Hubei Moxin Biotechnology Co., Ltd

Main products: Drug standards,Drug intermediates,Drug impurity reference,Peptide customization

mike
Current Location: HOME >> Product
Product Categories
Moxin Chemicals
Country: China
Tel:
Mobile: 17320513646
E-mail: mike@molcoo.com
QQ: 3001071511
Skype: Chat Now!
Address: Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
Product Name MF CAS Details
Grb2 SH2 Domain Ligand C23H36N5O10P 168423-05-0 Details
Acetalin 1, Opioid Receptor Antagonist 1 C42H61N11O8S2 152274-65-2 Details
[Tyr34]-pTH (7-34) amide (bovine) C156H244N48O40S2 86292-93-5 Details
Substance P (1-7) C41H65N13O10 68060-49-1 Details
Secretin Acetate, porcine C130H220N44O41 17034-35-4 Details
Somatostatin- 28 (1-14) C61H105N23O21S 79243-10-0 Details
Substance P (2-11)/Deca-Substance P C57H86N14O12S 53749-61-4 Details
RGD C12H22N6O6 99896-85-2 Details
Substance P (6-11)/Hexa-Substance P C36H52N8O7S 51165-07-2 Details
Secretin, rat C129H216N42O42 121028-49-7 Details
[Tyr27]-pTH (27-48) (human) C104H159N29O31 90686-51-4 Details
PAR-3 (1-6) amide (mouse) C25H36N8O8 261521-21-5 Details
Secretin, human C130H220N44O40 108153-74-8 Details
IL-1 Receptor Peptide (human) C47H88N14O12S 141801-03-8 Details
Somatostatin-14 (7-14) C49H66N10O12S 331627-76-0 Details
PAR-3 (1-6) amide (human) C29H46N10O7 1872435-09-0 Details
VIP Receptor-Binding Inhibitor L-8-K C50H77N9O12S 120550-85-8 Details
[Tyr52] PTH (52-84) (human) C158H262N44O56 89492-47-7 Details
[Leu8,D-Trp22,Tyr25]-Somatostatin-28 C138H209N41O40S2 77909-99-0 Details
[D-Arg1,D-Trp5,7,9,Leu11]-Substance P C81H110N20O12 122481-75-8 Details
SH2 Domain Ligand (2) C66H97N12O24P 147612-86-0 Details
[Sar9] Substance P C64H100N18O13S 77128-75-7 Details
pTH (3-34) (bovine) C175H274N52O48S2 51257-86-4 Details
[D-Trp8]-Somatostatin-14 C76H104N18O19S2 58976-46-8 Details
[D-Pro2,D-Phe7,D-Trp9]-Substance P C72H105N19O13S 77275-70-8 Details
[D-Arg1,D-Trp7,9,Leu11]-Substance P C75H108N20O13 91224-37-2 Details
[Tyr1] Somatostatin C82H108N18O20S2 59481-23-1 Details
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P C67H102N20O13S 115760-58-2 Details
Biotin-Somatostatin-14 C86H118N20O21S3 145251-83-8 Details
[Tyr11]-Somatostatin-14 C76H104N18O20S2 59481-27-5 Details
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P C75H108N20O13 84676-91-5 Details
[D-Phe7]-Somatostatin-14 C76H104N18O19S2 64813-74-7 Details
[Nle8’18,Tyr34]-pTH (1-34) amide (bovine) C185H293N55O50 64763-77-5 Details
FMRF - related peptide, Pyr - DPFLRFM - NH2 C44H61N11O10 98495-35-3 Details
[Nle8’21,Tyr34]-pTH (1-34) amide (rat) 105267-88-7 Details
Substance P (9-11) C13H26N4O3S 4652-64-6 Details
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P C79H109N19O12 96736-12-8 Details
[Tyr8] Substance P C63H98N18O14S 55614-10-3 Details
Substance P (1-9) C52H77N15O12 57468-17-4 Details
Somatostatin-28 C137H207N41O39S3 75037-27-3 Details
Tyr-Somatostatin-28 C146H216N42O41S3 86649-84-5 Details
PAR-2(1-6) (human) C28H53N7O8 202933-49-1 Details
pTH-Related Protein Splice Isoform 3 (140-173) (human) 139872-85-8 Details
[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11) C58H77N13O10 89430-34-2 Details
SH2 Domain Ligand (5) C41H62N7O16PS 201422-05-1 Details
[Asn10,Leu11,D-Trp12]-pTH-Related Protein (7-34) amide (human, rat) C162H254N50O36 129622-68-0 Details
RGD-4C C42H60N14O16S4 332179-76-7 Details
Sarafotoxin S6b C110H159N27O34S5 120972-53-4 Details
Substance P-methyl ester C64H99N17O14S 76260-78-1 Details
Ac-Choline Receptor α1(129-145) C90H136N22O28S2 194737-11-6 Details
Epidermal Growth Factor Receptor Peptide (985-996) C61H93N13O23 96249-43-3 Details
[Pyr5]-Substance P (5-11) C41H57N9O9S 56104-22-4 Details
Y-R-G-D-S C24H36N8O10 134282-68-1 Details
[Pyr6,Pro9]-Substance P (6-11) C39H53N7O7S 79775-19-2 Details
R-G-D-C C15H27N7O7S 109292-46-8 Details
R-G-D-S-P-A-S-S-K-P C40H68N14O16 91575-25-6 Details
[D-Pro4,D-Trp7,9,10]-Substance P (4-11) C62H74N14O10S 86917-57-9 Details
Substance P C63H98N18O13S 12769-48-1 Details
Biotin-Substance P C73H112N20O15S2 87468-58-4 Details
[D-Trp12,Tyr34]-pTH (7-34) amide (bovine) 118102-98-0 Details
[Pro9] Substance P C66H102N18O13S 104486-69-3 Details
[D-Pro2, D-Trp7,9]-Substance P C74H106N20O13S 80434-86-2 Details
PAR-4 (1-6) (human) C28H41N7O9 225779-44-2 Details
Substance P, Free Acid C63H97N17O14S 71977-09-8 Details
Substance P (5-11)/Hepta-Substance P C41H60N10O9S 51165-09-4 Details
PAR-4 (1-6) amide (mouse) C33H46N8O7 245443-52-1 Details
[D-Glu5,D-Trp7,9,10]-Substance P (5-11) C57H66N12O10S 289632-61-7 Details
Ac-Neurotrophin Receptor (368-381) amide (human) C69H124N22O19 197230-90-3 Details
[Asn76] PTH (64-84), human C94H163N27O35 129449-07-6 Details
Somatostatin- 25 C127H191N37O34S3 76461-17-1 Details
[Lys4] Sarafotoxin S6c C103H151N27O37S5 116495-45-5 Details
[D-Trp2,7,9]-Substance P C80H109N21O13S 100930-11-8 Details
Protease Activated Receptor - 2, PAR - 2 Agonist, amide C28H54N8O7 190383-13-2 Details
[Tyr43] PTH (43-68) (human) C126H208N42O43 92952-95-9 Details
[Nle11] Substance P C64H100N18O13 57462-42-7 Details
G-R-G-D-T-P C23H39N9O10 108682-58-2 Details
FMRF amide C29H42N8O4S 152165-14-5 Details
SH2 Domain Ligand (1) C36H56N7O13PS 157382-69-9 Details
KGF Receptor Peptide C114H174N30O42S 161338-76-7 Details
Somatostatin-14 (3-10) C52H72N12O11S 331627-82-8 Details
[Phe1,Ser2,Tyr6]-PAR-1 (1-6) amide (human) C39H60N10O8 245329-02-6 Details
Acetalin 3, Opioid Receptor Antagonist 3 C44H66N12O7S2 152274-67-4 Details
[Tyr1] -pTH (1-34), human 213779-10-3 Details
PAR-3 (1-6) (human) C29H45N9O8 320347-28-2 Details
[Pyr6]-Substance P (6-11) C36H49N7O7S 61123-13-5 Details
pTH (13-34) (human) C125H199N39O33S 81306-64-1 Details
Substance P (7-11) C31H44N6O5S 51165-05-0 Details
Sarafotoxin S6a C105H156N28O34S5 126738-34-9 Details
Tyr-Somatostatin-14 C85H113N19O21S2 58100-03-1 Details
[Tyr6,D-Phe7,D-His9]-Substance P (6-11) C44H57N9O7S 145194-26-9 Details
Substance P (4-11)/Octa-Substance P C46H67N11O10S 53749-60-3 Details
[Nle8’18,Tyr34]-pTH (3-34) amide (bovine) C177H279N53O48 64297-16-1 Details
NTB (Naltriben) C50H67N11O11S2 103429-31-8 Details
Secretin (5 - 27), porcine C115H200N38O34 19665-15-7 Details
pTH (28-48) (human) C95H150N28O29 83286-22-0 Details
Salusin-α C114H192N40O30 624735-22-4 Details
RGDV C17H31N7O7 93674-99-8 Details
Opioid receptor antagonist C44H66N14O7S2 152274-66-3 Details
Substance P (1-4) C22H40N8O5 57468-16-3 Details
Sarafotoxin S6c C103H147N27O37S5 121695-87-2 Details
Product Total: Product Page:
69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99